Sana Biotechnology's market cap is currently ―. The company's EPS TTM is $-1.463; its P/E ratio is -6.83; Sana Biotechnology is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -74.45M	$ -164.25M	$ -60.64M	$ -84.10M	$ -82.06M
EBITDA	$ -59.95M	-	$ -52.75M	$ -76.44M	$ -74.61M
Net Income Common Stockholders	$ 23.52M	$ -164.25M	$ -114.00M	$ -82.12M	$ -80.44M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 205.19M	$ 268.57M	$ 332.01M	$ 355.41M	$ 430.06M
Total Assets	$ 565.30M	$ 631.44M	$ 707.15M	$ 746.93M	$ 822.72M
Total Debt	$ 104.10M	$ 96.86M	$ 113.14M	$ 114.50M	$ 108.25M
Net Debt	$ -101.10M	$ -171.71M	$ -218.88M	$ -240.91M	$ -321.81M
Total Liabilities	$ 277.79M	$ 265.59M	$ 352.12M	$ 318.67M	$ 323.40M
Stockholders Equity	$ 287.51M	$ 365.85M	$ 355.03M	$ 428.26M	$ 499.31M
Cash Flow	-
Free Cash Flow	$ -66.00M	-	$ -54.87M	$ -86.95M	$ -80.67M
Operating Cash Flow	$ -51.96M	$ -63.55M	$ -53.30M	$ -84.78M	$ -76.07M
Investing Cash Flow	$ 15.31M	$ 51.35M	$ 37.17M	$ 68.19M	$ 88.43M
Financing Cash Flow	$ 1.72M	$ 187.00K	$ 29.50M	$ 236.00K	$ 1.06M

Currency in USD

Sana Biotechnology Earnings and Revenue History

Income Statement >

Sana Biotechnology Debt to Assets

Balance Sheet >

Sana Biotechnology Cash Flow

Cash Flow >

Sana Biotechnology Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing